Results 271 to 280 of about 250,417 (383)

Hypoglycemia in Ketotic Cows

, 1971
D. S. Kronfeld
openalex   +1 more source

Advanced Dialogues: From Laboratory to Clinics: Plant Cell‐Based Affordable Biologics

Advanced Genetics, EarlyView.
Henry Daniell
wiley   +1 more source

Temporal response patterns of human gut microbiota to dietary fiber

iMeta, EarlyView.
In this study, 19 overweight participants, with or without type 2 diabetes mellitus, underwent 14 days of normal‐diet observation followed by 14 days of dietary fiber intervention. Fecal samples and continuous glucose monitoring data were collected daily throughout the 28‐day period.
Xiaotong Lin, Chaoxun Wang, Biao Liu, Yin Zhu, Rui Zhai, Chenhong Zhang   +5 more
wiley   +1 more source

Trends in Diabetic Medication Use and Hypoglycemia Incidence Among Older Adults in Japan: A Retrospective Observational Study and a 10-Year Analysis Based on Level of Care Need Using Linked Medical and Long-Term Care Data. [PDF]

Cureus
Niida Y, Nishioka Y, Myojin T, Noda T, Takahashi Y, Imamura T.   +5 more
europepmc   +1 more source

Discovery of a novel tetrapeptide as glucose homeostasis modulator with bifunctionalities of targeting DPP‐IV and microbiota

iMeta, EarlyView.
AI‐driven and computation‐based high‐throughput methods were developed to mine novel dipeptidyl peptidase IV (DPP‐IV) inhibitory peptides from hemp seed proteins. The identified peptide VAMP demonstrates a glucose‐lowering effect through dual mechanisms: inhibition of DPP‐IV activity and selective promotion of intestinal Akkermansia muciniphila growth.
Haihong Chen, Wei Li, Wei Hu, Junyu Liu, Canyang Zhang, Yi Wang, Chong Zhang, Xizhen Zhang, Shuo Chen, Qixing Nie, Xinhui Xing   +10 more
wiley   +1 more source

Case Report: Role of hypoglycemia in seizure aggravation in a case of focal epilepsy: revealing a missing link between diabetes and dementia. [PDF]

Front Neurosci
Ohara H, Yamanaka M, Inoue K, Shimizu H, Iguchi N, Tanaka K, Gopalakrishnan AV, Vellingiri B, Kinoshita M.   +8 more
europepmc   +1 more source

Primary Care Providers' and Staff Confidence and Awareness of Continuous Glucose Monitors Following Pharmacist‐Led Education and Training: A Pre‐Post Cohort Study

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
ABSTRACT Continuous glucose monitoring (CGM) is an effective and convenient method for assessing glucose control for both patients and providers. Over the years, guidelines have strengthened recommendations with regard to CGM, and payors have improved coverage.
Amber Lilly, Cynthia A. King, Jasmin Ortiz   +2 more
wiley   +1 more source

Personalized machine learning models for noninvasive hypoglycemia detection in people with type 1 diabetes using a smartwatch: Insights into feature importance during waking and sleeping times. [PDF]

PLoS One
Mohamed YM, Mancera J, Brandenberg A, Fischli S, Havranek MM.   +4 more
europepmc   +1 more source

Diagnosis and treatment of ACTH-producing pituitary tumors [PDF]

, 1978
Baur, X., Bayer, J. M., Fahlbusch, R., Fahlbusch, R., Madler, M., Marguth, F., Müller, O. A., Scriba, Peter Christian, Uhlig, C., Werder, Klaus von   +9 more
core   +1 more source

Effects of Hepatic or Renal Impairment on Pharmacokinetics of Fruquintinib

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fruquintinib (FRUZAQLATM) is a highly selective tyrosine kinase inhibitor of all three vascular endothelial growth factor receptors (‐1, ‐2, and ‐3). Two Phase 1, open‐label, single‐dose studies investigated the impact of hepatic or renal impairment on the pharmacokinetics and tolerability of fruquintinib.
Martha Gonzalez, Zhao Yang, William Schelman, Thomas C. Marbury, Juan C. Rondon, William Smith, Xiaofei Zhou, Neeraj Gupta, Caly Chien   +8 more
wiley   +1 more source